Patents by Inventor André CHOLLET

André CHOLLET has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2?-methyl-1,1?-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime, and methods of using the same
    Patent number: 10752583
    Abstract: Crystalline (3Z,S3)-5-(hydroxymethyl)-1-[(2?-methyl-1,1?-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime is disclosed. A pharmaceutical composition containing the crystalline compound and methods for treating conditions related to the OT-R activity, such as preterm labor, and for increasing embryo implantation rate in a mammal undergoing embryo transfer, comprising administering the crystalline compound are also disclosed.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: August 25, 2020
    Assignee: ObsEva S.A.
    Inventor: André Chollet
  • CRYSTALLINE (3Z,5S)-5-(HYDROXYMETHYL)-1-[(2'-METHYL-1,1'-BIPHENYL-4-YL)CARBONYL]PYRROLIDIN-3-ONE O-METHYLOXIME, AND METHODS OF USING THE SAME
    Publication number: 20170320822
    Abstract: Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2?-methyl-1,1?-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime is disclosed. A pharmaceutical composition containing the crystalline compound and methods for treating conditions related to the OT-R activity, such as preterm labor, and for increasing embryo implantation rate in a mammal undergoing embryo transfer, comprising administering the crystalline compound are also disclosed.
    Type: Application
    Filed: May 25, 2017
    Publication date: November 9, 2017
    Inventor: André CHOLLET
  • Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2?-methyl-1,1?-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime, and methods of using the same
    Patent number: 9718772
    Abstract: Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2?-methyl-1,1-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime is disclosed. A pharmaceutical composition containing the crystalline compound and methods for treating conditions related to the OT-R activity, such as preterm labor, and tor increasing embryo implantation rate in a mammal undergoing embryo transfer, comprising administering the crystalline compound are also disclosed.
    Type: Grant
    Filed: June 10, 2015
    Date of Patent: August 1, 2017
    Assignee: ObsEva S.A.
    Inventor: André Chollet
  • CRYSTALLINE (3Z,5S)-5-(HYDROXYMETHYL)-1-[(2'-METHYL-1,1'-BIPHENYL-4-YL)CARBONYL]PYRROLIDIN-3-ONE O-METHYLOXIME, AND METHODS OF USING THE SAME
    Publication number: 20160002160
    Abstract: Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2?-methyl-1,1-biphenyl-4-yl) carbonyl]pyrrolidin-3-one O-methyloxime is disclosed. A pharmaceutical composition containing the crystalline compound and methods for treating conditions related to the OT-R activity, such as preterm labor, and tor increasing embryo implantation rate in a mammal undergoing embryo transfer, comprising administering the crystalline compound are also disclosed.
    Type: Application
    Filed: June 10, 2015
    Publication date: January 7, 2016
    Inventor: André CHOLLET